drugset / Trial / NCT06639659

Sphenopalatine Block vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery

NCT06639659 ↗

Active not recruiting 69 enrolled Zagazig University
RandomizedParallel-groupTriple-blindHealth-services research

Summary

Improving pain and surgical field by using sphenopalatine ganglion block and dexmedetomidine in trans-nasal endoscopic pituitary surgery.

Timeline

Start
2024-10-01
Primary completion
2026-10
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg —

Indications